Dr. ASHUTOSH MISHRA

Associate Professor, Dept of Surgical Oncology

DR BRA IRCH & National Cancer Institute (NCI)

All India Institute of Medical Sciences, New Delhi, India

 

MCh Surgical Oncology (AIIMS, New Delhi), Fellow UICC 

FACS, FEBS, FSSO, Fellow-ESSO, FARIS (Robotic Surgery)

MBBS, MS (Gen Surgery), FAIS, FMAS, FIAGES 

MBA (Hospital & Health care Management) 

 

Director of Education- Association of Breast Surgeons of India [2024-2026]

Treasurer IASO - Indian Association of Surgical Oncology [2025-2027]

Member- ASCO-India Advisory Group [2025-2026]

Member Scientific Committee SSO- Society of Surgical Oncology, USA [2024-2026]

National Representative - European Society of Surgical Oncology (ESSO)-[2024-2026]

Treasurer- Delhi Oncology Forum [2024-2027]

Member Social Media Committee- Breast Surgery International (BSI), Switzerland, [2024-2026]

Member Abstract Review Committee UICC 2024- UICC, Geneva

Board of Directors- Breastics24 (Senaturk, Türkiye)

Associate Editor- Annals of Breast Diseases (An ABSI Journal)

Ex- Executive Member- Indian Association of Surgical Oncology [2021-2023]

Ex- Executive Member ABSI- Association of Breast Surgeons of India [2022-2024]

Executive Member- Delhi Oncology Forum [2021-2024]

Ex-Mentor for the International Papilloma Virus Society (IPVS) Mentorship Program [2023-24]

Ex- Editorial Secretary IASO - Indian Association of Surgical Oncology [2023-2025]

Orchid ID-https://orcid.org/0000-0002-5390-5482

 

Fellowships

• FUICC : Fellow Union for International Cancer Control, Geneva (2024)

• FEBS: Fellow of European Board of Surgery (Breast Surgery), 2025

• FACS: Fellow of American College of Surgeons, USA (2020)

• FSSO: Fellow of the Society of Surgical Oncology, USA (2023)

• FARIS: Fellowship in Advanced Robotic & Innovative Surgery (2024)

• Fellow-ESS0: Fellow European Society of Surgical Oncology (2022)

• FAIS: Fellow of Association of Surgeons of India (2015)

• FMAS - Fellow of Minimal Access Surgery (AMASI, India), 2016)

• FIAGES - Fellow of Indian Association of GI Endosurgeons, 2016

• IASO SSO International Fellowship 2022 (Dallas, USA)

• IASO SSO International Fellowship 2024 (Atlanta, USA)

• UHNM Visiting Fellow 2022– University Hospitals of North Midlands (UHNM), UK

• Charite Visiting Fellow 2023- Charite Medical University, Berlin, Germany

• Visiting Fellow 2024- MSKCC New York, USA

• Visiting Fellow 2025- Mayo Clinic Visiting Fellow 2025- Florida, USA

• Visiting Fellow 2025 Royal Victoria Infirmary, NOGU - Newcastle upon Tyne, UK

• Visiting Fellow 2025- Walsall Manor Hospital Visiting Fellow (UICC), Birmingham, UK

• Visiting Fellow 2025- North Tees University Hospital Visiting Fellow, North Tees, UK

• Visiting Fellow 2025-Westmed Breast Cancer Institute, University of Sydney, Australia

• Visiting Fellow 2025- University of Brussels, Belgium

 

Awards & Scholarships

1. UICC Technical Fellowship 2024, Geneva

2. ABSI-New Delhi Young Scientist Award 2021 (ABSICON 2021, Kolkata)

3. Association of Breast Surgeons (ABS-UK Birmingham) LMI Bursary 2025

4. IASO-SSO Fellowship (USA) 2023 in 3^rd Indian Cancer Congress, Mumbai 2023

5. IASO Best Oral Paper Presentation Award in 3^rd Indian Cancer Congress, Mumbai 2023

6. BSI Best Poster Award by International Society of Surgery (ISS/ SIC), Vienna 2022

7. Breast Surgery International (BSI) Travel Award for Young Surgeons (Vienna, 2022)

8. IASO- SSO travelling Fellowship Dallas, Texas, USA, 2021

9. Council Of Scientific And Industrial Research (CSIR) PFA International Travel Grant Award (Berlin, 2023)

10. The Cancer Foundation (Rotary) Travel Award for World Cancer Congress Geneva, 2022.

11. CAGI Geneva travel grant for World Cancer Congress Geneva, 2022

12. International Cancer Foundation (ICF) Registration Scholarship 2023- European Lung Cancer Congress 2023, Copenhagen, Denmark (Virtual)

13. International Cancer Foundation (ICF) Registration Scholarship 2023- ESMO Gynaecological Cancer Congress Barcelona, Spain 2023

14. International Cancer Foundation (ICF) Registration Scholarship 2023- ESMO Immuno Oncology Congress, Geneva, 2023

15. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Congress Paris.

16. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Asia Congress Singapore.

17. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Breast cancer Congress Berlin.

18. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Gynaecological Cancer Congress Valencia, Spain (Online) 2022

19. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Molecular Analysis for Precision Oncology (MAP) congress 2022, Amsterdam , Netherlands.

20. Indian Council of Medical Research (ICMR) International Travel Grant Award (Barcelona, 2018)

21. Council Of Scientific And Industrial Research (CSIR) International Travel Grant Award (Spain, 2018)

22. European Cancer Congress Fellowship Grant Award for ECCO 2017 held at Amsterdam, Netherlands.

23. European Society of Medical Oncology Travel Grant Award for ESMO Preceptorship on GI Tumor ,Singapore(2017)

24. Best Oral Paper in 34^th National Conference of Indian Association of Surgical Oncology (NATCON IASO 2021)

25. International Cancer Foundation (ICF) Registration Scholarship 2021- ESMO Congress

26. International Cancer Foundation (ICF) Registration Scholarship 2022- European Lung Cancer Congress 2022

27. International Cancer Foundation (ICF) Registration Scholarship 2022- ESMO Sarcoma & GIST Symposium

28. Best oral paper category award in National conference of Association of Breast surgeons of India ( ABSICON 2016)

29. Best Poster Award in 12th International Conference of Asian Clinical Oncology Society (ACOS 2016)

30. NATCON Best Photography Award, NATCON IASO 2021.

31. Rank- 3, FARIS: Fellowship in Advanced Robotic & Innovative Surgery (2024)

32. First Rank in AIIMS MCh Surgical Oncology Entrance Exam

33. First Rank in AIIMS MCh Surgical Oncology Exit Exam

34. First Rank in Final MBBS I -professional exam

 

Certifications

• UICC Certificate course on “Essentials of Leadership and Management for CSOs in Cancer Control”, 2024 (Union for International Cancer Control, Geneva)

• UICC Certificate course on “Access to Essential Cancer Medicines” , 2024; (Union for International Cancer Control, Geneva)

• FARIS- Fellowship in Advanced Robotic & Innovative Surgery (2024) affiliated SRMC & Royal College of Surgeons Edinburgh, UK

• Breast Surgery International (BSI) Oncoplastic & Reconstructive Breast Surgery Course, Vienna 2022

• ESMO Advanced course on Sarcoma & GIST 2022

• UICC Master-course (Malaysia 2018)-Building cancer awareness and prevention programmes (Preventive Oncology)

• ESMO Preceptorship on GI Tumors (Singapore, 2017)

• Certificate Course in Advance Laparoscopy , AIIMS, New Delhi, India

• AMASI Laparoscopic Skill Course (India), 2016

• Certificate course in Pain and Palliative care (Indian association of Palliative Care , IAPC , 2016)

• MRCS A (UK) (2016)

• MBA (Hospital & Healthcare Management), NIBM, India (2015)

• MBA (Operation) NIBM, India,2015

 

International Clinical Observerships & Workshops

 

• NOGU Robotic UGI Surgery Clinical Observership 2025, Royal Victoria Infirmary, NOGU - Newcastle upon Tyne, UK [ Mentor- Prof Arul Immanuel ]

• Reconstructive Breast Surgery Clinical Observership 2025, Walsall Manor Hospital (UICC), Birmingham, UK [ Mentor- Dr Iqbal Kasana ]

• Robotic Colorectal Surgery Clinical Observership 2025, North Tees University Hospital Visiting Fellow, North Tees, UK [ Mentor- Dr Gurpreet Singh ]

• Reconstructive Breast Surgery Clinical Observership 2025, Westmed Breast Cancer Institute, University of Sydney, Australia [ Mentor- Dr Farid Meybodi & Elizabeth Elder ]

• Reconstructive Breast Surgery Clinical Observership 2025, Department of Plastic Surgery, University of Brussels, Belgium [ Mentor- Prof Moustapha Hamdi ]

• Mayo’s ClinicMinimally Invasive Hepatopancreaticobiliary Clinical Observership 2025, Jacksonville, Florida, USA. [ Mentor- Prof John Stauffer]

• MSKCC Robotic Gynaecologic and Colorectal Surgery Clinical Observership 2024 – Memorial Sloan Kettering Cancer Centre (MSKCC), New York, US. (Mentor- Dr Mario J Leitao )

• HIPEC & PIPAC in Gastrointestinal Cancer Clinical Observership 2023 ( Germany)- Department of Special Surgical Oncology (CVK), Charite Medical University, Berlin, Germany (Mentor- Prof Dr Beate Rau)

• Robotic Colorectal Clinical Observer ship 2022 (United Kingdom)- The Royal Stoke University Hospital, University Hospitals of North Midlands, Stoke on Trent, United Kingdom (Mentor- Dr V Garimella & Dr Philip Varghese )

• Breast Oncoplasty Clinical Observership 2022 (United Kingdom)- The Royal Stoke University Hospital & County hospital Staffordshire, University Hospitals of North Midlands, UK

• BSI Advanced Oncoplastic & Reconstructive Breast Surgery workshop, Vienna Medical University,Vienna, Austria (2022) (Dr Ashutosh Kothari, London)

• Multidisciplinary breast healthcare and Oncoplastic Breast Surgery Observership program at SENATURK affiliated Hospitals- Istanbul University Institute of Oncology, (Turkiye 2024) (Prof. M. Bahadir Gulluoglu)

 

Course Director-

• OBSCG Oncoplastic Breast Surgery Workshop-(ABSI & IASO affiliated)

• Robotic Breast Surgery and Reconstructive workshop- (ABSI, IASO, ARIS affiliated) 

 

 

Memberships

 

International

1. Member of Society of Surgical Oncology (SSO; No- 123724)

2. Member of American College of Surgeons (ACS; No- 3354417)

3. Member of American Society of Clinical Oncology (ASCO; No. 552592)

4. Member of European Society of Surgical Oncology (ESSO; No.6982)

5. Member of European Society of Gynaecological Oncology ( ESGO : 153954)

6. Member International Society of Gynaecologic Cancer (IGCS)

7. Member of Society of European Robotic Gynaecological Surgery (SERGH:1390061)

8. Member of European Society of Medical Oncology ( ESMO: No. 505930

9. Member of International Society of Surgery – ISS -20200101

10. Member of International Society of Digestive Surgery- ISDS-2021

11. International Papillomavirus Society (IPVS)- 2023

12. Breast Surgery International- BSI 2020

National (Indian)

13. Life Member of Indian Association Of Surgical Oncology (IASO, M-0082)

14. Life Member of Association of Robotic and Innovative Surgery (ARIS-0162)

15. Life member of The Association of Surgeons of India (FL30145) 

16. Life Member of Indian Society of Oncology (ISO) (N-M;109)

17. Life Member of Association of Breast Surgeons of India (ABSI)(FL-000410)

18. Life Member of Indian society of Peritoneal Surface Malignancies (ISPSM)

19. Life Member of Association of Gynaecologic Oncologist of India (AGOI-1448)

20. Life member of Indian Association of Gastrointestinal Endosurgeons (IAGES -4426) 

21. Life member of Association of Minimal Access Surgeons of India (AMASI -5528)

22. Life member of Society of Endoscopic and Laproscopic surgeons of India (SELSI-2406)

23. Life member of  Delhi Oncology Forum (No. 60/2015)

 

 

Book chapters/ Monograph Published ()

 

1. Mishra, A., Ray, M.D. (2021). Comprehensive Surgical Training & Mentorship: Foundation of the Excellent Onco-surgical Services. In: Ray, M.D. (eds) Multidisciplinary Approach to Surgical Oncology Patients. Springer, Singapore. https://doi.org/10.1007/978-981-15-7699-7_30

 

2. Mishra, A., Mandal, A., Deo, S.V.S. (2025). Clinical Approach to Symptomatic Breast and Triple Assessment. In: Dhamija, E., Deo, S.V.S. (eds) Imaging in Management of Breast Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-97-9847-6_3

 

3. Deo, S.V.S., Mishra, A., Kumar, C., Bhoriwal, S. (2023). Margin Assessment in Breast Conserving Surgery. In: Deo, S. (eds) Breast Oncoplasty and Reconstruction. Springer, Singapore. https://doi.org/10.1007/978-981-99-5536-7_5

 

4. Deo, S.V.S., Kumar, N., Mishra, A. (2023). Volume Replacement: Latissimus Dorsi Mini-Flap (LDMF) for Partial Breast Reconstruction. In: Deo, S. (eds) Breast Oncoplasty and Reconstruction. Springer, Singapore. https://doi.org/10.1007/978-981-99-5536-7_19

 

5. Deo, S.V.S., Mishra, A., Kumar, C., Goyal, A. (2023). Follow-Up and Cosmetic Outcomes in Breast Oncoplasty. In: Deo, S. (eds) Breast Oncoplasty and Reconstruction. Springer, Singapore. https://doi.org/10.1007/978-981-99-5536-7_35

 

6. SVS Deo, Mishra, A.(2023) Management of early breast Cancer. In: Sarkar, D. (eds) Breast Diseases.Taylor & Francis. http://dx.doi.org/10.1201/9780367821982-13

 

7. SVS Deo , Ashutosh Mishra, MD Ray (2018). Types and techniques of Cytoreductive Surgery, Handbook of Peritoneal Surface Malignancies , Cytoreductive Surgery And HIPEC, Selina Publishers Pvt Ltd, New Delhi 38-50.

 

8. SVS Deo , Ashutosh Mishra (2018).  Patient selection and scoring systems for CRS and HIPEC, Handbook of Peritoneal Surface Malignancies , Cytoreductive Surgery And HIPEC, Selina Publishers Pvt Ltd, New Delhi, 63-70.

 

9. SVS Deo , Ashutosh Mishra, MD Ray (2018).  Resources for CRS & HIPEC Handbook of Peritoneal Surface Malignancies , Cytoreductive Surgery And HIPEC, Selina Publishers Pvt Ltd, New Delhi, 156-158.

 

10. Mishra A, Rathee A. Postoperative Approach-Follow-up After Oncoplastic Breast Surgery. In: Cantürk NZ, editor. Essential of Oncoplastic Breast Surgery Techniques. 1st ed. Ankara: Türkiye Clinics; 2026. p.497-508. http://doi.org/10.5336/978-625-395-828-2_p497

 

Paper Published (last 5 years)

 

2026

1. Ashutosh Mishra, SVS Deo, Chinmay Bagla, et al. , Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection, Clinical Breast Cancer (2026), doi: https://doi.org/10.1016/j.clbc.2026.02.014(Impact Factor-2.7)

 

2. Ajay Gogia, Atul Batra, Ashutosh Mishra et al.,Pertuzumab–Docetaxel–Trastuzumab Regimen in HER2-Positive Metastatic Breast Cancer: Real-World Data from India, Cancer Treatment and Research Communications, 2026, https://doi.org/10.1016/j.ctarc.2026.101196. (Impact Factor-2.4)

 

3. Babul Bansal, Venugopal Ravi, Rakesh Garg, Ashutosh Mishra, et al., Enhanced Recovery After Surgery in Cytoreductive Surgery With HIPEC: Implementation and Outcomes from a High‐Volume Tertiary Centre in a Lower‐Middle Income Country, Journal of Surgical Oncology (2026),https://doi.org/10.1002/jso.70257(Impact Factor-1.9)

 

4. Pathak, B., Kumar, S., Deo, S. Mishra A et al. Young-Onset Rectal Cancer is Overlooked: Outcome Analysis from a Tertiary Cancer Centre in North India. Indian J Surg Oncol 17, 908–916 (2026). https://doi.org/10.1007/s13193-026-02594-8(Impact Factor-0.8)

 

5. Divya Khanna, ……, Ashutosh Mishra….., Whole-Genome Landscape of Breast Cancers from India shows Distinct Clinically Actionable Subtypes. medRxiv 2026.03.27.26349506;  https://doi.org/10.64898/2026.03.27.26349506

 

 

2025

 

1. Mishra, A., Kumar, A., Deo, S.V.S. et al. No-Doppler Medial Intercostal Artery Perforator Flap for Partial Breast Reconstruction: Surgical Technique, Feasibility, and Outcomes in Inner and Central Quadrant Defects. Indian J Surg Oncol (2025). https://doi.org/10.1007/s13193-025-02448-9

 

2. Correspondence on “Key issues in diagnostic accuracy of sentinel lymph node biopsy in early-stage ovarian cancer: Systematic review and meta-analysis” by Rey et al. International Journal of Gynecological Cancer,Volume 35, Issue 1,2025,100015,ISSN 1048-891X, https://doi.org/10.1016/j.ijgc.2024.100015 (Impact Factor-4.5)

 

3. Thakur, R., Deo, S., Dhamija, E. , Mishra A. et al. Contrast Mammogram versus Digital Mammogram for Evaluation of Multifocal and Multicentric Breast Cancer—A Prospective Study. Indian J Surg Oncol (2025). https://doi.org/10.1007/s13193-025-02243-6

4. Pathak, N., Mittal, A., Kumar, S., Nagpal, C., Amir, E., Haldar, P., Gangadharaiah, B. B., Kumar, A., Mishra, A., & Batra, A. (2025). Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors. Current Oncology, 32(1), 53. https://doi.org/10.3390/curroncol32010053(Impact Factor-2.8)

 

5. Thakur, R., Deo, S.V.S., Dhamija, E. Mishra A. et al. Comparison of Contrast-Enhanced Mammography with MRI for Preoperative Assessment of Breast Cancer: A Pilot Study.Indian J Surg Oncol (2025). https://doi.org/10.1007/s13193-025-02417-2

 

6. Deo, S., Pathak, B., Sharma, J., Kumar, S., Bhoriwal, S., Mishra, A., Mandal, A., Saikia, J., Barwad, A., Thulkar, S., Sharma, D. and Bakhshi, S. (2025), Temporospatial Recurrence Patterns and Predictive Factors for Recurrences in 984 Patients With Adult Soft Tissue Sarcomas. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70027(Impact Factor-3.5)

 

7. Mouna BM,  Batra A,  Sharma V,.. Mishra A, et al.  Metformin with neoadjuvant chemotherapy in localized triple-negative and Her2neu-positive breast cancer: a prospective phase 2 open-label randomized controlled trial (McBETH). Cancer.  2025;e70205. https://doi.org/10.1002/cncr.70205(Impact Factor-5.1)

 

8. Abhilash Dagar MD , Adrija Ghosh MD , Abhinav Singhal MD , Akash Kumar DM , Jyoti Sharma Mch , Aman Sharma MD , Ashutosh Mishra Mch , Atul Batra DM , Ajay Gogia DM , Jaswin Raj M.Sc , Sangeeta Hazarika M.Sc , Pritee B Chaudhari MD , Surendra Kumar Saini MD , Dayanand Sharma MD , SVS Deo Mch , Supriya Mallick MD, DNB , A study of curative approach treatment along with metastasis-directed SBRT in bone-only oligometastatic breast cancer, International Journal of Radiation Oncology, Biology, Physics (2025), doi: https://doi.org/10.1016/j.ijrobp.2025.11.047 (Impact Factor-6.5)

 

9. Arora A, Bhaskarane H, Tansir G, ………..Mishra A,…….Batra A, A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial – Pembrolizumab Low Dose in Addition to NACT in TNBC], Annals of Oncology (2026), doi: https://doi.org/10.1016/j.annonc.2025.12.015(Impact Factor-65.4)

 

10. Ajay Gogia, Atul Batra, Ashutosh Mishra, et al. Pertuzumab/Docetaxel/Carboplatin/Trastuzumab Regimen in Human Epidermal Growth Factor Receptor 2–Positive Early, Locally Advanced, and Oligometastatic Breast Cancer: Real-World Outcomes From India. JCO Glob Oncol 11, e2500273(2025). DOI:10.1200/GO-25-00273(Impact Factor-3.3)

 

11. Bansal, B., Malik, K., Krishnamurthy, S.S. Mandal A, Mishra A,et al. Role of Retroperitoneal Lymph Node Dissection in Management of Seminomatous Germ Cell Tumor: A Narrative Review. Indian J Surg Oncol 16, 910–915 (2025). https://doi.org/10.1007/s13193-024-02170-y

 

12. Somashekhar, S.P., Garg, P.K., Deo, S. … Mishra A….et al. ABSI 2025 Consensus Guidelines on the Management of Breast Cancer in Low- and Middle-Income Countries. Indian J Surg Oncol(2025). https://doi.org/10.1007/s13193-025-02429-y

 

13. Ansari MN, Jha SK, Khan A, Rajput K, Pandey N, ….Mishra A….et al. (2025) The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms. PLOS Biology 23(9): e3003362. https://doi.org/10.1371/journal.pbio.3003362

 

2024

14. Mishra, A., Deo, S.V.S., Kumar, N. et al. A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low- to Middle-Income Country. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15527-y (Impact Factor-4)

 

15. Mishra, Ashutosh; Kapoor, Rohan; Sharma, Daya Nand¹; Saini, Surendra K.¹. Implant-based immediate breast reconstruction and adjuvant radiotherapy. Journal of Cancer Research and Therapeutics 20(6):p 1669-1670, Oct–Dec 2024. https://doi.org/10.4103/jcrt.jcrt_1627_24 (Impact Factor-1.4)

 

16. Comprehensive germline profiling of patients with breast cancer: initial experience from a Familial Cancer Clinic ecancer 18 1670 (2024). https://doi.org/10.3332/ecancer.2024.1670

 

17. Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas. Clin Oncol (R Coll Radiol). 2024 2024 Apr;36(4):e97-e104. https://doi.org/10.1016/j.clon.2024.01.018. Epub 2024 Feb 1. PMID: 38326122.

 

18. Role of Retroperitoneal Lymph Node Dissection in Management of Seminomatous Germ Cell Tumor: A Narrative Review. Indian J Surg Oncol (2024).https://doi.org/10.1007/s13193-024-02170-y 

 

2023

 

19. Mishra, A., Deo, S.V.S., Oberoi, A.S. et al. No Doppler Single Position-Lateral Intercostal Artery Perforator Flap (NDSP-LICAP): a Safe and Versatile Flap for Breast Oncoplasty in Resource-Limited Setting. World J Surg (2023).https://doi.org/10.1007/s00268-023-07126-x. (Impact Factor- 3.28)

 

20. Bilateral Breast Cancer: Clinical Profile and Management. Indian J Surg Oncol (2023). https://doi.org/10.1007/s13193-023-01731-x

 

21. Pattern of Care in Real-World Scenario on Advanced Epithelial Ovarian Cancer in a Tertiary Referral Oncology Centre in India — ISPSM Collaborative Study. Indian J Surg Oncol (2023). https://doi.org/10.1007/s13193-023-01746-4

 

22. Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India. Cancers. 2023; 15(11):2973. https://doi.org/10.3390/cancers15112973 (Funded by: Cancer Research UK & DBT India, Impact Factor- 6.8)

 

23. Re-operative surgery for differentiated thyroid cancer: A single institutional experience of 182 cases. European Journal of Surgical Oncology, Volume 49, Issue 10,2023, https://doi.org/10.1016/j.ejso.2023.107042 (Impact Factor- 3.8) 

 

 

2022

24. Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy – an Analysis of Critical Perioperative and Surgical Outcomes among 155 Peritoneal Surface Malignancy Patients Treated at a Tertiary Care Cancer Centre, Clinical Oncology, 2022, ISSN 0936-6555, https://doi.org/10.1016/j.clon.2022.03.003. (Impact Factor- 3.4)

 

25. Caregivers and end stage ovarian cancer survivorship- a correlation, Annals of International Medical & Dental Research, 2023, E ISSN 2395-2822, P ISSN 2395-2814, Vol 9 issue 1, page 44-50

 

2021

 

26. A Pilot Study Evaluating Sentinel Lymph Node Biopsy Using Dual Dye Technique with ICG and Methylene Blue for Early Breast Carcinoma (EBC). Indian J Surg (2021). https://doi.org/10.1007/s12262-021-03124-2 (Impact Factor- 0.4)

 

27. Impact of COVID-19 Pandemic on Cancer Surgical Services—AIIMS, New Delhi Experience. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01478-3(Impact Factor- 0.62)

 

28. A Review of Surgical Perspectives of Breast Cancer Genetics and Risk-Reducing Surgery. Indian J Surg (2021). https://doi.org/10.1007/s12262-021-03119-z (Impact Factor- 0.4)

 

29. Clinical outcomes and technical description of unstented end to side pancreaticogastrostomy by small posterior gastrotomy. Ann Hepatobiliary Pancreat Surg. 2021 May 31;25(2):251-258. doi: 10.14701/ahbps.2021.25.2.251. PMID: 34053928; PMCID: PMC8180407.

 

30. Complex and Challenging Surgery like CRS with HIPEC is Easible Midst the COVID 19 Pandemic: Experience from Tertiary Care Center in India. Indian J Gynecol Oncol. 2021;19(4):66. doi: 10.1007/s40944-021-00558-0. Epub 2021 Jul 17. PMID: 34307832; PMCID: PMC8286034. (Impact Factor- 0.34)

 

31. Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study. Head & Neck. 2021; 1- 9. doi:10.1002/hed.26904 (Impact Factor- 3.82)

 

32. Standard Groin Dissection Versus “River Flow” Incision Technique - A Comparative Cost Analysis at An Indian Tertiary Care Cancer Institute.International Journal Of Scientific Research : volume-10 | issue-5 | May-2021

2020

 

33. Management options for gynecological cancers in low- to middle-income countries amidst COVID-19 pandemic. J Cancer Res Pract 2020;7:121-6. http://doi.org/10.4103/JCRP.JCRP_14_20

 

34. Gangliocytic Paraganglioma of Ampulla Masquerading as a Neuroendocrine Tumor. J Gastrointest Canc (2020).https://doi.org/10.1007/s12029-020-00507-8 (Impact Factor- 1.6)

 

35. Vulvar cancer: surgical management and survival trends in a low resource setting. J Egypt Natl Canc Inst 32, 4 (2020). https://doi.org/10.1186/s43046-019-0015-y (Impact Factor- 1.8)

 

36. Comment on: Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy. Br J Surg (2020), 107: e665-e665. https://doi.org/10.1002/bjs.12045 (Impact Factor- 6.939)

 

37. Renal cell carcinoma arising in an open pyelolithotomy scar: A perplexing scenario!. J Curr Oncol 2020;3:93-6 http://doi.org/10.4103/jco.jco_26_20

 

38. Double trunk of recurrent laryngeal nerve—A rare anatomical variation.Surgery (2020). http://doi.org/10.1016/j.surg.2020.04.023  (Impact Factor- 3.8)

 

39. Thoracoabdominal Flap: a Simple Flap for Covering Large Post-mastectomy Soft Tissue Defects in Locally Advanced Breast Cancer. Indian J Surg Oncol 10, 494–498 (2019). https://doi.org/10.1007/s13193-019-00927-4(Impact Factor- 0.62)

 

40. Effect of barium sulphate and gastrografin dye on wound healing in the gastro-intestinal tract of albino rat-an experimental study. International journal of scientific research : volume-8 | issue-5 | may-2019

 

41. Minimizing Post-operative Complications of Groin Dissection Using Modified Skin Bridge Technique: A Single-Centre Descriptive Study Showing Post-operative and Early Oncological Outcomes. World J Surg 42, 3196–3201 (2018). https://doi.org/10.1007/s00268-018-4604-z(Impact Factor- 3.28)

 

Abstracts Published (Last 5 years)

1. Mishra, A., Deo, S.V.S., Kumar, N. et al. ASO Visual Abstract: A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low–Middle Income Country. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15696-w(Impact Factor- 4)

 

2. Outcome with pertuzumab, docetaxel, and trastuzumab (PTH) regimen in patients with HER2 positive metastatic breast cancer: Real-world data from a single center in India. (ASCO 2024), J Clin Oncol 42, 2024 (suppl 16; abstr e13037) ; (Impact Factor- 45.3) DOI: 10.1200/jco.2024.42.16_suppl.e13037

 

3. Neoadjuvant pertuzumab, docetaxel, carboplatin, and trastuzumab (PTCH) regimen in patients with HER2 positive early, locally advanced, and oligometastatic breast cancer: Real-world Indian. (ASCO 2024), J Clin Oncol 42, 2024 (suppl 16; abstr e12556) ; (Impact Factor- 45.3); https://doi.org/10.1200/JCO.2024.42.16_suppl.e12556

 

4. Acute radiation morbidities and dosimetric evaluation of DARS structures: Results from the phase III randomized SWOAR trial.. J Clin Oncol 42, 2024, TPS149-TPS149(2024). DOI:10.1200/JCO.2024.42.23_suppl.TPS149, (Impact Factor- 45.3)

 

5. Role of Circulating Tumor DNA (Ct-DNA) as a Surrogate Marker in Ovarian Cancer - A Pilot Study, Society of Surgical Oncology SSO 2024 Annual Meeting. Ann Surg Oncol 31 (Suppl 1), 1–294 (2024). https://doi.org/10.1245/s10434-024-15179-y(Impact Factor- 4.4)

 

6. Awareness and knowledge regarding Genetic breast cancer in LMIC- A questionnaire-based study of 300 patients” ESMO Openvolume 8, issue 1, supplement 4, 101453, May 2023, https://doi.org/10.1016/j.esmoop.2023.101453(Impact Factor- 5.4)

 

7. Pattern of axillary lymph node involvement and scope of post neoadjuvant chemotherapy sentinel lymph node biopsy among breast cancer patients in developing countries. ESMO Open, Volume 8, issue 1, supplement 4, 101487, May 2023, https://doi.org/10.1016/j.esmoop.2023.101487(Impact Factor- 5.4)

 

8. Validation of surgical peritoneal cancer index (SPCI) as a prognostic marker in ovarian cancer patients undergoing interval cytoreductive surgery & hyperthermic intraperitoneal chemotherapy (ICS-HIPEC), International Journal of Gynecologic Cancer 2023;33:A287.DOI: 10.1136/ijgc-2023-esgo.597(Impact Factor- 4.8)

 

9. Mishra A, Deo S, Bhoriwal S.Modified LICAP turn-over flap - A simple reconstructive technique for large breast lumpectomy defects in resource constrained environment. European Journal of Surgical Oncology 2022, Vol 48, Issue 5, p.e189-e246 https://doi.org/10.1016/j.ejso.2022.03.177 (Impact Factor- 3.8)

 

10. Mishra A, Ray M, Deo S, et al 2022-RA-1436-ESGO Pelvic exenteration – boon or a bane ? Analysis from tertiary care cancercentre International Journal of Gynecologic Cancer 2022;32:A59-A60. http://doi.org/10.1136/ijgc-2022-ESGO.129 (Impact Factor- 4.8)

 

11. Role of ICG Fluorescence Imaging in Management of Neck Nodes in Oral Cancer- A Prospective Comparative Study, Society of Surgical Oncology SSO 2022 - International Conference on Surgical Cancer Care. Ann Surg Oncol 29 (Suppl 2), 331–544 (2022). https://doi.org/10.1245/s10434-022-11828-2(Impact Factor- 4.4)

 

12. Mishra A, Ray M, Deo S, et al. Upfront CRS versus NACT followed by CRS in advanced EOC in Indian patients -an analytical retrospective study International Journal of Gynecologic Cancer 2021;31:A228.http://dx.doi.org/10.1136/ijgc-2021-ESGO.387(Impact Factor- 4.8)

 

13. Ray M, Surya T *, Mishra A. Cytoreductive surgery after neoadjuvant chemotherapy in ovarian cancer: Does neoadjuvant chemotherapy really ease the burden? Journal of Gynaecologic Oncology 2022, http//doi.org/10.3802/jgo.2021.32.S1.OO4

    • (*Young Gynaecologic Oncologist Award for the abstract during the 7^th Biennial meeting of Asian Society of Gynaecologic Oncology, Bangkok, Thailand, 2021) (Impact Factor- 4.4)

 

14. “Improvement in quality of life of Indian breast cancer patients by pre and post mastectomy educational counselling” titled abstract published in International Journal of Gynaecological Cancer,Vol-29, Issue suppl-4, Nov 2019. (Impact Factor- 4.8)

 

15. “Quality of life in Gynaecological cancers and tools for its improvements- An Indian Perspective” titled abstract published in Journal of Global Oncology (An ASCO Journal),Vol no 4, suppl_2, Oct 2018. (Impact Factor- 4.5)

 

16. "Development of ‘Online Cancer Patient Assistance Pathway’ (OCPAP™) technology platform to provide treatment guidance for cancer patients in developing countries. (Onco.com) titled poster published in ASCO Breakthrough, Thailand, 2019 . (ASCO Conquer Cancer Foundation Award)

 

17. Awareness and Knowledge regarding genetic aspect of Breast Cancer in LMIC : A prospective questionnaire based study published in Abstract Book World Congress of Surgery, Poland, 2019.

 

18. “Impact of revision surgery timing on overall survival in incidentally detected gall bladder cancer: An experience from tertiary care centre of Northern India” titled abstract published in Annals of Oncology, Vol 29, Issue suppl_5, jun 2018. (Impact Factor- 32.976)

 

 

International Paper Presentations / Lectures (last 5 years)

1. “Is Incidental gall bladder cancer in endemic region truly incidental?
   Long- term oncological outcomes of Incidental gall bladder cancer patients
   following curative resection” titled oral paper presentation at International Surgical week (ISW 2024) 50^th World Congress of the International Society of Surgery ISS/SIC, Kuala Lumpur, Malaysia, 27^th August, 2024. ISDS Kitajima Prize session. (Best 4 Abstracts) 

2. Do all the Gall bladder cancer patients with stage IV have similar outcomes? and Prognostic factors affecting the survival of surgically treated Gall bladder cancer patients titled oral paper presentation at International Surgical week (ISW 2024) 50^th World Congress of the International Society of Surgery ISS/SIC, Kuala Lumpur, Malaysia, 27^th August, 2024. 

3. “Prospective Study Evaluating Feasibility, Cosmetic Outcomes, Stress, Satisfaction Levels and Quality of Life in Patients Undergoing Risk Reducing Surgery at Tertiary Care Cancer Centre in LMIC” titled oral paper presentation at International Surgical week (ISW 2024) 50^th World Congress of the International Society of Surgery ISS/SIC, Kuala Lumpur, Malaysia, 27^th August, 2024. Breast Surgery International (BSI) Free paper Prize Session. 

4. Clinical Grand Round (CGR) presentation atThe Royal Stoke University Hospital, University Hospitals of North Midlands, Stoke on Trent, United Kingdom, 27^th May 2022 (Topic - “Genetic Mutations and Risk Reducing Surgery for Breast Cancer”)

5. “STUMP THE EXPERTS: TRAVEL SCHOLARS PRESENTATION” oral presentation, session 126, during the International Surgical Week ISW22022, World Congress of Surgery, in Vienna, Austria,August 15-18, 2022.

6. “Awareness and knowledge regarding Genetic breast cancer in LMIC- A questionnaire-based study of 300 patients” titled oral paper presentation at World Cancer Congress 2022, Geneva, Switzerland (The Cancer Foundation and CAGI Grant)

7. “An Exploratory Study to Identify Circulating Free and Tumor DNA as a Surrogate Markers of Ovarian Cancer- A Novel Approach.” titled Paper presentation at 3^rd Indian Cancer Congress 2023, Mumbai (IASO-SSO Fellowship Award 2023)

8. Modified LICAP Turn-over flap- A simple reconstructive technique for large breast lumpectomy defects in resource constrained environment” titled Paper presentation at 3^rd Indian Cancer Congress 2023, Mumbai

9. “HBOC Awareness in India- AIIMS Experience” title paper presented in Indian Cancer Genetics & Genomic Conference – ICGGC, Nov 2020 (AIIMS & The Genomic Medicine Foundation {UK} )

10. Awareness and Knowledge regarding Genetic aspects of Breast Cancer in LMIC prospective Questionnaire based Study of 300 Patients , 34^th NATCON IASO 2021

(Best Oral Paper for IASO Awards & SSO Fellowship)

11. Breast Cancer in Elderly -IRCH AIIMS, New Delhi Experience titled paper presented in 18th Annual conference of the Women’s Cancer Initiative- Tata Memorial Hospital, Oct 2020.

12. “Thoraco-abdominal flap: A simple flap for covering large post mastectomy soft tissue defects in locally advanced breast cancer” titled Paper presented in National conference of Association of Breast Surgeons of India (ABSICON 2016, 1-3july, Bengaluru, India) – Best Oral Paper Category Award

International Poster Presentations (last 5 years)

 

1. “An Exploratory Study to Identify Circulating Free and Tumor DNA as a Surrogate Markers of Ovarian Cancer- A Novel Approach.” titled Poster presentation at Society of Surgical Oncology (SSO- 2024) Atlanta, Georgia (USA) [IASO-SSO Fellowship, 2023]

 

2. “An Exploratory Study to Identify Circulating Free and Tumor DNA as a Surrogate Markers of Ovarian Cancer- A Novel Approach.” titled Poster presentation at European Society of Surgical Oncology (ESSO - 2024) Antwerp, Belgium.

 

3. “Pattern of axillary lymph node involvement and scope of post neoadjuvant chemotherapy sentinel lymph node biopsy among breast cancer patients in developing countries” titled Poster presentation at ESMO Breast 2023, Berlin, Germany

 

4. “Awareness and knowledge regarding Genetic breast cancer in LMIC- A questionnaire-based study of 300 patients” titled Poster presentation at ESMO Breast 2023, Berlin, Germany

 

5. “Modified LICAP Turn-over flap- A simple reconstructive technique for large breast lumpectomy defects in resource limited environment” titled poster presented in International Surgical Week ISW22022, World Congress of Surgery, in Vienna, Austria,August 15-18, 2022. (BSI Best poster Award, 2022)

 

6. “Pelvic exenteration: Boon or a Bane? Analysis from tertiary care cancer centre” titled poster presented in 23^rd European Congress on Gynaecological Oncology 2022, Berlin Germany. (accepted)

 

7. “Pattern of Lymph Node Involvement and Impact of Neoadjuvant therapy among 418 rectal cancer patients undergoing curative surgery” titled Poster presented in International Surgical Week ISW22022, World Congress of Surgery, in Vienna, Austria,August 15-18, 2022.

 

8. “Modified LICAP Turn-over flap- A simple reconstructive technique for large breast lumpectomy defects in resource constrained environment” titled poster presented in Association of Breast Surgery Conference, ABS 2022 Liverpool, UK.

 

 

9. Modified Lateral Intercostal Artery Perforator flap (LICAP) Turn-over flap for reconstruction of lumpectomy defects titled poster presented in 10^th Annual Conference of ABSI (ABSICON 2021, Kolkata, India); ABSI- New Delhi Young Scientist Award.

 

10. Ovarian Nodal Cancer Index (ONCI) - A Proposed Prognostic Index titled poster presented in 34^th annual conference of Indian Association of Surgical Oncology (NATCON IASO 2021)

 

11. Surgical Outcomes of Pelvic Exenterations for Advanced Malignancies in a North Indian Tertiary Care Cancer Center titled poster presented in 34^th annual conference of Indian Association of Surgical Oncology (NATCON IASO 2021)

 

12. "Development of ‘Online Cancer Patient Assistance Pathway’ (OCPAP™) technology platform to provide treatment guidance for cancer patients in developing countries. (Onco.com) titled poster presented in ASCO Breakthrough, Thailand, 2019 . (ASCO Conquer Cancer Foundation Award)

 

13. A prospective interventional study evaluating awareness and knowledge of Indian Breast Cancer Patients about genetic aspect of Breast Cancer and the effect of educational intervention; 5^th INDIAN CANCER GENETICS CONFERENCE & WORKSHOP held at TMC Mumbai on 15^th Dec 2019.

 

14. "Impact of lymph node positivity on overall survival in operable gall bladder cancer: An experience from tertiary cancer care centre from Northern India" titled poster presented at ESMO 20th World Congress on Gastrointestinal Cancer , 20-23 June 2018 ,Barcelona, Spain.  

 

15. "Quality of life in gynaecological cancers and tools for its improvement: An Indian perspective" titled poster presented in UICC World Cancer Congress 2018, 1st -4th oct 2018, Kuala Lumpur, Malaysia  

 

16. Impact of revision surgery timing on overall survival in incidentally detected gall bladder cancer: An experience from tertiary care centre of Northern India", titled poster presented in ESMO 20th World Congress on Gastrointestinal Cancer , 20-23 June 2018, Barcelona, Spain.